Application of recombinant antibodies in cancer patients.
Krauss
Jürgen
J
National Cancer Institute at Frederick, Frederick, MD, USA.
Arndt
Michaela
M
Pfreundschuh
Michael
M
D000818:Animals; D000906:Antibodies / Q000276:immunology / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006801:Humans; D007128:Immunoglobulin Fragments; D051379:Mice; D008822:Mice, Transgenic; D009369:Neoplasms / Q000175:diagnosis* / Q000628:therapy*; D011994:Recombinant Proteins / Q000627:therapeutic use
D000906:Antibodies; D007128:Immunoglobulin Fragments; D011994:Recombinant Proteins